Laboratorio Reig Jofre, S.A. (BME:RJF)
2.480
-0.020 (-0.80%)
Mar 5, 2026, 12:19 PM CET
Laboratorio Reig Jofre Revenue
In the year 2025, Laboratorio Reig Jofre had annual revenue of 336.68M EUR, down -1.37%. Laboratorio Reig Jofre had revenue of 94.68M in the quarter ending December 31, 2025, with 7.17% growth.
Revenue
336.68M
Revenue Growth
-1.37%
P/S Ratio
0.60
Revenue / Employee
234.29K
Employees
1,426
Market Cap
203.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 336.68M | -4.69M | -1.37% |
| Dec 31, 2024 | 341.37M | 23.42M | 7.36% |
| Dec 31, 2023 | 317.95M | 43.74M | 15.95% |
| Dec 31, 2022 | 274.21M | 34.34M | 14.32% |
| Dec 31, 2021 | 239.87M | 6.11M | 2.61% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Almirall | 1.11B |
| Faes Farma | 571.12M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 240.68M |
| Oryzon Genomics | 7.36M |
| Atrys Health | 226.24M |